In the past few years, new technology advances and a focus on oncology testing have been hot topics in digital pathology, artificial intelligence (AI) and image analysis. In addition, cancer rates have been steadily increasing despite the breakthroughs in personalized medicine and treatment plans.
In 2019, over 268,000 new cases of breast cancer were diagnosed in women in the U.S. alone, and it is the second-leading cause of death among women. Similarly, ovarian cancer causes more deaths each year than any other gynecologic cancer in the U.S. These numbers are staggering and put a spotlight on the time, resources and dollars invested in research and development of technologies and methodologies to help reduce those numbers and improve the odds of survival for patients who are diagnosed with these, and other, cancers.
